The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Bariatric Surgeries Increased After ACA Expansion, But Not for All Racial/Ethnic Backgrounds
October 12th 2021A comparison of data from expansion states and nonexpansion states suggests access to bariatric surgery has increased since the ACA Medicaid expansion, but the increase in access has been limited mainly to non-Hispanic White patients.
Metabolically Healthy Obesity Still Carries Increased Risk of Heart Failure, Arrhythmia
September 29th 2021New data presented at EASD 2021 suggests patients with metabolically healthy obesity were at a 34% greater risk of developing new-onset heart failure and a 33% greater risk of new-onset AF than counterparts of healthy weight and no metabolic abnormalities.
Major Weight Loss Could Return Cardiovascular Risk to Normal Levels in Patients with Obesity
September 28th 2021An analysis of NHANES data presented at EASD 2021 details the effects of returning to a healthy weight among patients with obesity compared to those currently with obesity and those who always maintained a healthy weight.
Trial Results Suggest Healthy Eating Patterns Could Reduce Cardiovascular Risk in Pediatric Patients
September 22nd 2021A Cleveland Clinic trial assessing the effects of 3 healthy eating patterns in children with overweight or obesity details the improvements in cardiovascular risk factors seen with adherence to a healthy eating pattern.
AHA Outlines Weight Loss Strategies for Preventing Obesity Hypertension
September 20th 2021Released on September 20, the latest scientific statement from the AHA outlines potential strategies, including lifestyle modifications, pharmacologic therapies, and weight loss surgery, for the prevention and treatment of obesity hypertension.